Skip to main content

Table 4 Multivariable analyses of risk factors of pneumothorax in STS patients during pazopanib treatment

From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

Variate

Adjusted Odds ratio

95 % CI

p-value

Maximum dia. of lung lesions ≥ 30 mm

13.3

1.1–155.4

0.039

History of pneumothorax

16.6

1.1–256.1

0.045